Duohai Pan
About Duohai Pan
Duohai Pan is a Senior Principal Scientist at Bristol-Myers Squibb, specializing in protein aggregation and particulate formation.
Current Position at Bristol-Myers Squibb
Duohai Pan currently holds the position of Senior Principal Scientist at Bristol-Myers Squibb, located in the Greater New York City Area. In his role, he leverages his extensive expertise to advance the company's scientific research and development initiatives.
Previous Role at Bristol-Myers Squibb
Duohai Pan worked as a Senior Research Investigator II at Bristol-Myers Squibb from 2009 to 2015. Based in New Brunswick, NJ, he contributed to numerous projects, focusing on various aspects of pharmaceutical research and development over his six-year tenure.
Education and Academic Background
Duohai Pan earned a Doctor of Philosophy - PhD in Physical Chemistry from The University of Hong Kong. He furthered his studies at the University of California, Berkeley, where he completed a postdoctoral program in Physical Chemistry from 2000 to 2003. His advanced education laid the foundation for his contributions to the field of pharmaceutical science.
Expertise in Protein Aggregation and Particulate Formation
Specializing in the detection and characterization of protein aggregation and particulate formation, Duohai Pan focuses on the impact of interfacial processes on proteins to support protein formulation development. His work is instrumental in ensuring the stability and efficacy of protein-based therapeutic products.
Solid-State Characterization Skills
Duohai Pan has specialized knowledge in solid-state characterization of active pharmaceutical ingredients (APIs), excipients, and drug products. This expertise is vital for understanding how different materials behave under various conditions, which is essential for developing reliable and effective pharmaceuticals.
Analytical Method Development
In his research, Duohai Pan develops analytical methods using vibrational spectroscopy. These methods are crucial for understanding the impact of manufacturing and formulation processes on the attributes and performance of materials, thereby supporting the development of high-quality pharmaceutical products.